For decades, software developers have been slipping jokes into their work. One of the most enduring, clever, and geekily satisfying inside jokes has been hiding in plain sight: the recursive acronym.

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

The surface of Earth is finite. We can measure it. If it was expanding, then its size would grow with time. And once again, good ol' Earth helps us understand what the universe might be doing beyond ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Despite the odds being stacked against it and a rough launch, 'Halo Infinite' grew into its own good thing over time. Reading time 3 minutes On December 8, 2021, 343 Industries released Halo Infinite.

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

GameSpot may get a commission from retail offers. The time of Halo: Infinite is coming to a close. Microsoft and Halo Studios have revealed that the game's next major update, Operation: Infinite, will ...

Active development on Halo Infinite will end on the same day that Operation: Infinite kicks into gear: 18th November. Released in 2021, Halo Infinite was announced amid a 10-year plan to "continu[e] ...

This month’s content update for Halo Infinite is its last, as the team focuses on ‘multiple’ Halo titles in development. This month’s content update for Halo Infinite is its last, as the team focuses ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...